+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05844982

Comparing Intravitreal Faricimab Injections and Fluocinolone Acetonide Implants to Observation for Preventing Vision Loss from Radiation Retinopathy After Choroidal Melanoma Treatment

Led by Jaeb Center for Health Research · Updated on 2026-10-23

600

Participants Needed

29

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how intravitreal faricimab injections and fluocinolone acetonide intravitreal implants compare with observation in preventing long-term vision loss caused by radiation retinopathy after treatment of choroidal melanoma using iodine-125 plaque brachytherapy. This Phase 3 randomized trial aims to assess whether repeated treatments can improve visual acuity outcomes and alter the progression of macular edema resulting from radiation damage to the retina. Participants will be randomly assigned to one of three groups repeated faricimab injections, fluocinolone acetonide intravitreal implants, or observation with treatment only if macular edema develops. Faricimab is given as a 6.0 mg intravitreal injection at the start and every 3 months thereafter. The fluocinolone acetonide implant 0.19 mg is placed at the beginning and again at 24 months. The observation group receives no initial treatment but is monitored closely. During the study, participants will undergo vision tests to measure changes in visual acuity over 3 years. Imaging techniques including widefield color photos, fluorescein angiography, and OCT angiography will track retinal changes and macular edema development. Researchers will monitor safety, visual outcomes, and the natural course of radiation retinopathy. The total study duration extends up to the primary completion date, nearly six years after the start, allowing for long-term evaluation.

CONDITIONS

Brief Title

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Research Team

C

Cynthia Stockdale, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here